LINGO-1 shRNA Loaded by Pluronic F-127 Promotes Functional Recovery After Ventral Root Avulsion.

Abstract

Spinal root avulsion typically leads to massive motoneuron death and severe functional deficits of the target muscles. Multiple pathological factors such as severe neuron loss, induction of inhibitory molecules, and insufficient regeneration are responsible for the poor functional recovery. Leucine-rich repeat and immunoglobulin-like domain-containing Nogo receptor-interacting protein 1 (LINGO-1), a central nervous system (CNS)-specific transmembrane protein that is selectively expressed on neurons and oligodendrocytes, serves as a potent negative mediator of axonal regeneration and myelination in CNS injuries and diseases. Although accumulating evidence has demonstrated improvement in axonal regeneration and neurological functions by LINGO-1 antagonism in CNS damage, the possible effects of LINGO-1 in spinal root avulsion remain undiscovered. In this study, a LINGO-1 knockdown strategy using lentiviral vectors encoding LINGO-1 short hairpin interfering RNA (shRNA) delivered by the Pluronic F-127 (PF-127) hydrogel was described after brachial plexus avulsion (BPA). We provide evidence that following BPA and immediate reimplantation, transplantation of LINGO-1 shRNA lentiviral vectors encapsulated by PF-127 rescued the injured motoneurons, enhanced axonal outgrowth and myelination, rebuilt motor endplates, facilitated the reinnervation of terminal muscles, improved angiogenesis, and promoted recovery of avulsed forelimbs. Altogether, these data suggest that delivery of LINGO-1 shRNA by a gel scaffold is a potential therapeutic approach for root avulsion. Impact Statement In this study, we attempted transplantation of lentivirus (LV)/leucine-rich repeat and immunoglobulin-like domain-containing Nogo receptor-interacting protein 1 (LINGO-1)-short hairpin interfering RNA (shRNA) encapsulated by the Pluronic F-127 (PF-127) hydrogel into a brachial plexus avulsion (BPA)-reimplantation model. We found that administration of LV/LINGO-1 shRNA facilitates neuron survival and axonal regeneration, attenuates muscle atrophy and motor endplate (MEP) loss, enhances neovascularization, and promotes functional recovery in BPA rats. Co-transplantation of LV/LINGO-1 shRNA and gel reinforces the survival-promoting effect, axonal outgrowth, and angiogenesis in comparison with LV/LINGO-1 shRNA application alone. Our research provides evidence that LV /LINGO-1 shRNA delivered by PF-127 represents a new treatment strategy for BPA repair.

• Authors: Lu Ding, Zhe Zhu, Yuhui Wang, Lini Zeng, Tao Wang, Jiang Luo, Tang-Bin Zou, Rui Li, Xuerong Sun, Guangji Zhou, Xiaoqian Liu, Hong-Fu Wu
• Journal: Tissue engineering. Part A (Tissue Eng Part A) Vol. 25 Issue 19-20 Pg. 1381-1395 (10 2019) ISSN: 1937-335X [Electronic] United States
• PMID: 30794055 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• LINGO1 protein, rat
• Membrane Proteins
• Nerve Tissue Proteins
• RNA, Small Interfering
• Poloxamer

Topics

• Animals
• Axons (pathology)
• Brachial Plexus (injuries)
• Cell Survival
• Female
• Gene Transfer Techniques
• Lentivirus (genetics)
• Membrane Proteins (metabolism)
• Motor Endplate (pathology)
• Motor Neurons (pathology)
• Muscular Atrophy (pathology)
• Myelin Sheath (pathology)
• Neovascularization, Physiologic
• Nerve Regeneration
• Nerve Tissue Proteins (metabolism)
• Poloxamer (chemistry)
• RNA, Small Interfering (administration & dosage)
• Rats, Sprague-Dawley
• Recovery of Function
• Spinal Nerve Roots (injuries, physiopathology, ultrastructure)